Tumor Necrosis Factor News and Research

RSS
Scientists rewire mouse stem cells to fight inflammation caused by arthritis

Scientists rewire mouse stem cells to fight inflammation caused by arthritis

‘Geneva signature’ evaluates safety and immunogenicity of promising anti-Ebola virus vaccine

‘Geneva signature’ evaluates safety and immunogenicity of promising anti-Ebola virus vaccine

Researchers develop prognostic tool that predicts risk of kidney failure in diabetes patients

Researchers develop prognostic tool that predicts risk of kidney failure in diabetes patients

Gut microbes cause age-associated inflammation and premature death, mice study shows

Gut microbes cause age-associated inflammation and premature death, mice study shows

Tumor necrosis factor may help control blood pressure, study suggests

Tumor necrosis factor may help control blood pressure, study suggests

Study provides new understanding of molecular mechanisms of HPV-induced tumors

Study provides new understanding of molecular mechanisms of HPV-induced tumors

Research helps elucidate mechanisms behind low-level laser therapy in treating neuropathic pain

Research helps elucidate mechanisms behind low-level laser therapy in treating neuropathic pain

Scientists identify molecules that may be key to drug resistance in estrogen-driven breast cancers

Scientists identify molecules that may be key to drug resistance in estrogen-driven breast cancers

Researchers develop new assay for measuring underlying autoimmunity in rheumatoid arthritis patients

Researchers develop new assay for measuring underlying autoimmunity in rheumatoid arthritis patients

Researchers reveal how inflammatory responses block fat cell conversion

Researchers reveal how inflammatory responses block fat cell conversion

New research offers valuable insight for developing more effective drugs to treat IBD

New research offers valuable insight for developing more effective drugs to treat IBD

Scientists identify cell-surface receptor for progranulin

Scientists identify cell-surface receptor for progranulin

Karolinska Institute biologist receives 2016 Naomi Berrie Award for excellence in diabetes research

Karolinska Institute biologist receives 2016 Naomi Berrie Award for excellence in diabetes research

Arthritis drug induces response and remission in patients with Crohn's disease, study finds

Arthritis drug induces response and remission in patients with Crohn's disease, study finds

UAB researchers show how aging and excess dietary fat lead to heart failure

UAB researchers show how aging and excess dietary fat lead to heart failure

Preconsumption of red wine can prevent short-term vascular injury caused by smoking

Preconsumption of red wine can prevent short-term vascular injury caused by smoking

Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

Status uncertainty may be risk factor for acute diseases, study shows

Status uncertainty may be risk factor for acute diseases, study shows

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.